Impaired synaptic plasticity in RASopathies: a mini-review

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of neural transmission

• Publication date

  2016-08-26

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/s00702-016-1609-3PMID 27565148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanism and treatment for the learning and memory deficits associated with mouse models of Noonan syndrome

  2014cited by this paper
• The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.

  2014cited by this paper
• Abnormal experimentally- and behaviorally-induced LTP-like plasticity in focal hand dystonia.

  2013cited by this paper
• Impaired induction of long‐term potentiation‐like plasticity in patients with high‐functioning autism and Asperger syndrome

  2013cited by this paper
• Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.

  2013cited by this paper
• Impaired motor cortex plasticity in patients with Noonan syndrome.

  2013cited by this paper
• Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1

  2013cited by this paper
• The RASopathies.

  2013cited by this paper
• Transcranial magnetic stimulation in dystonia.

  2013cited by this paper
• Dystonia in Costello syndrome.

  2012cited by this paper
• Abnormal plasticity in dystonia: Disruption of synaptic homeostasis.

  2011cited by this paper
• The time course of motor cortex plasticity after spaced motor practice.

  2011cited by this paper
• Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study.

  2011cited by this paper
• Loss of topographic specificity of LTD-like plasticity is a trait marker in focal dystonia.

  2011cited by this paper
• Enhanced human brain associative plasticity in Costello syndrome

  2010cited by this paper
• Neurofibromin regulates corticostriatal inhibitory networks during working memory performance

  2010cited by this paper
• Transcranial Magnetic Stimulation Provides Means to Assess Cortical Plasticity and Excitability in Humans with Fragile X Syndrome and Autism Spectrum Disorder

  2010cited by this paper
• The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.

  2009cited by this paper
• Short latency intracortical inhibition: one of the most popular tools in human motor neurophysiology

  2009cited by this paper
• Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

  2009cited by this paper
• Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms

  2008cited by this paper
• Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning.

  2008cited by this paper
• Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system.

  2008cited by this paper
• Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.

  2008cited by this paper
• Neurofibromin regulation of ERK signaling modulates GABA release and learning.

  2008cited by this paper
• Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia

  2007cited by this paper
• Cortical plasticity in Alzheimer's disease in humans and rodents.

  2007cited by this paper
• An unexpected new role of mutant Ras: perturbation of human embryonic development

  2007cited by this paper
• Task-specific hand dystonia: can too much plasticity be bad for you?

  2006cited by this paper
• Plasticity of the motor cortex in Parkinson's disease patients on and off therapy

  2006cited by this paper
• The role of GABA(B) receptors in intracortical inhibition in the human motor cortex.

  2006cited by this paper
• The role of GABAB receptors in intracortical inhibition in the human motor cortex

  2006cited by this paper
• The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.

  2005cited by this paper
• LTP and LTD: an embarrassment of riches.

  2004cited by this paper
• Paired associative stimulation.

  2004cited by this paper
• Long-term potentiation and memory.

  2004cited by this paper
• Learning Modifies Subsequent Induction of Long-Term Potentiation-Like and Long-Term Depression-Like Plasticity in Human Motor Cortex

  2004cited by this paper
• MAPK cascade signalling and synaptic plasticity

  2004cited by this paper
• Impaired sequence learning in carriers of the DYT1 dystonia mutation

  2003cited by this paper
• Review Article : Molecular and Cellular Mechanisms Underlying the Cognitive Deficits Associated With Neurofibromatosis 1

  2002cited by this paper
• Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

  2002cited by this paper
• Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation

  2002cited by this paper
• Modulation of intracortical inhibition induced by low- and high-frequency repetitive transcranial magnetic stimulation

  2001cited by this paper
• Induction of plasticity in the human motor cortex by paired associative stimulation.

  2000cited by this paper
• The pathophysiology of primary dystonia.

  1998cited by this paper
• A mouse model for the learning and memory deficits associated with neurofibromatosis type I

  1997cited by this paper
• Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex.

  1994cited by this paper
• Corticocortical inhibition in human motor cortex.

  1993cited by this paper
• An Embarrassment of Riches

  1992cited by this paper

• Acute administration of lovastatin had no pronounced effect on motor abilities, motor coordination, gait nor simple cognition in a mouse model of Angelman syndrome

  2025cites this paper
• Non-Mammalian Models for Understanding Neurological Defects in RASopathies

  2024cites this paper
• Exploring the Role of Neuroplasticity in Development, Aging, and Neurodegeneration

  2023cites this paper
• Improvement of synaptic plasticity and cognitive function in RASopathies—a monocentre, randomized, double-blind, parallel-group, placebo-controlled, cross-over clinical trial (SynCoRAS)

  2023cites this paper
• Multimodal assessment of the GABA system in patients with fragile-X syndrome and neurofibromatosis of type 1.

  2022cites this paper
• Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies

  2021cites this paper
• Neurocutaneous disorders

  2020cites this paper
• Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome

  2019cites this paper
• Excitatory neuron–specific SHP2-ERK signaling network regulates synaptic plasticity and memory

  2019cites this paper
• Targeted Molecular Sequencing Revealed Allelic Heterogeneity of BRAF and PTPN11 Genes among Arab Noonan Syndrome Patients

  2018cites this paper
• Altered Brain Cholesterol/Isoprenoid Metabolism in a Rat Model of Autism Spectrum Disorders.

  2018cites this paper
• Neuronale Plastizität und Neuromodulation in der Kinderneurologie

  2018cites this paper
• Chapter 2 Learning Disability in RASopathies

  2018cites this paper
• Structural fingerprints, interactions, and signaling networks of RAS family proteins beyond RAS isoforms

  2018cites this paper
• Targeted Molecular Sequencing Revealed Allelic Heterogeneity of BRAF and PTPN11 Genes among Arab Noonan Syndrome Patients

  2018cites this paper
• [Learning disorders in neurofibromatosis type 1].

  2017cites this paper
• Learning Disability in RASopathies

  2017cites this paper
• Oligodendrocyte RasG12V expressed in its endogenous locus disrupts myelin structure through increased MAPK, nitric oxide, and notch signaling

  2017cites this paper
• Cognitive Dysfunctions in Intellectual Disabilities: The Contributions of the Ras-MAPK and PI3K-AKT-mTOR Pathways.

  2017cites this paper
• Role of mevalonate pathway in the central nervous system

  2017cites this paper